Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

Autor: Kerr DJ (AUTHOR), Dunn JA (AUTHOR), Langman MJ (AUTHOR), Smith JL (AUTHOR), Midgley RSJ (AUTHOR), Stanley A (AUTHOR), Stokes JC (AUTHOR), Julier P (AUTHOR), Iveson C (AUTHOR), Duvvuri R (AUTHOR), McConkey CC (AUTHOR), VICTOR Trial Group (CORPORATE AUTHOR)

Publikováno v: New England Journal of Medicine. 7/26/2007, Vol. 357 Issue 4, p360-369. 10p.